


Healthcare News Roundup: Neurology
HSMN NewsFeed - 7 May 2013
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
